Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 3 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
metro group[Corporate Author]
(112 results)?
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
JAMA Netw Open. 2024 Mar 4;7(3):e241215. doi: 10.1001/jamanetworkopen.2024.1215.
JAMA Netw Open. 2024.
PMID: 38446479
Free PMC article.
Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis.
Maiorano BA, De Giorgi U, Verzoni E, Maiello E, Procopio G, Conteduca V, Di Maio M; MeetURO group.
Maiorano BA, et al.
Target Oncol. 2024 Jan;19(1):1-11. doi: 10.1007/s11523-023-01016-x. Epub 2023 Nov 22.
Target Oncol. 2024.
PMID: 37993604
Free PMC article.
Item in Clipboard
Correction to: Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis.
Maiorano BA, De Giorgi U, Verzoni E, Maiello E, Procopio G, Conteduca V, Di Maio M; MeetURO group.
Maiorano BA, et al.
Target Oncol. 2024 Jan;19(1):127. doi: 10.1007/s11523-023-01025-w.
Target Oncol. 2024.
PMID: 38070004
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.